<DOC>
	<DOC>NCT00284037</DOC>
	<brief_summary>Individuals with obstructive sleep apnea syndrome (OSAS) are at high risk for cardiovascular morbidity and mortality. The effect of long-term nocturnal therapy with continuous positive airway pressure (CPAP) on daytime baroreflex sensitivity (BRS), a predictor of cardiac death, was investigated in OSAS patients.</brief_summary>
	<brief_title>Improvement in Baroreflex Sensitivity in OSAS</brief_title>
	<detailed_description />
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>obstructive sleep apnea syndrome diabetes mellitus, chronic obstructive lung disease, coronary or valvular heart disease, congestive heart failure, renal failure, or endocrine dysfunction. Moreover, none of them were taking bblockers, vasodilators, or inotropic agents at the time of enrollment in the study.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2005</verification_date>
	<keyword>obstructive sleep apnea,</keyword>
	<keyword>baroreceptors</keyword>
</DOC>